Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. Shareholder Equity 2010–2025
Lifecore Biomedical, Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lifecore Biomedical, Inc. shareholder equity as of May 25, 2025: 1.3M, a 88.19% decrease year-over-year.
- Lifecore Biomedical, Inc. shareholder equity for 2025 were 1.3M, a 88.19% decrease from 2024.
- Lifecore Biomedical, Inc. shareholder equity for 2024 were 11.3M, a 367.49% decrease from 2023.
- Lifecore Biomedical, Inc. shareholder equity for 2023 were -4.2M, a 104.82% decrease from 2022.
- Lifecore Biomedical, Inc. shareholder equity for 2022 were 87.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lifecore Biomedical, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2024 | $11 |
| 2023 | $-4 |
| 2022 | $88 |
| 2021 | $202 |
| 2020 | $230 |
| 2019 | $270 |
| 2018 | $253 |
| 2017 | $227 |
| 2016 | $211 |
| 2015 | $218 |
| 2014 | $203 |
| 2013 | $179 |
| 2012 | $150 |
| 2011 | $136 |
Lifecore Biomedical, Inc. Shareholder Equity — FAQ
Lifecore Biomedical, Inc. (LFCR) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LFCR's shareholder equity history?
The chart and table above show Lifecore Biomedical, Inc.'s shareholder equity by year and by quarter, including the growth rate.